China Medical Biotech Association

Welcome to Bio-VC Forum 2008 Theme：Invest in Biotechnology, Invest for the Future Time：October 11-13, 2008 Venue: Dalian Modern Museum Dalian · China, 2008

VC Forum Agenda

Presented by

& BIT Life Sciences, Inc., China

OCTOBER 10, 2008, FRIEDAY 08:30-18:00 Registration
OPENING CEREMONY & WELCOME SPEECHES DAY ONE: OCTOBER 11, 2008, SATURDAY
07:00-08:30 / REGISTRATION AND CONTINENTAL BREAKFAST
08:15-08:30 / Group Picture
09:00-09:30 / OPENING CEREMONY & WELCOME SPEECHES
VIP ADDRESSES Moderator: Xiaodan Mei, Ph.D. President of BIT Life Sciences, Inc., China WELCOME Xiaodan Mei, Ph.D., President & CEO, BITeomics, Inc., China OPENING REMARKS – CONFERENCE CHAIR Mr. Hailin Liu , Deputy Director General, China Medicinal Biotech Association WELCOME SPEECHES FROM ORGANIZERS AND HOSTS
-1. Leader of Local Municipal Government
-1. David A. Palella, President, BioScience Ventures, Inc., USA
09:30-12:00 / OPENING FORUM: KEYNOTE SPEECHES Session Chair: Xiaodan Mei, Ph.D. President & CEO, BIT Life Sciences, Inc., China
09:30-10:00 / Keynote Speech: Big Pharma and its Relationship with VC and Biotech Mr. Alex Fowkes, Head of Strategic Alliances, Asia, Global Research & Development, Pfizer (China) Research and Development Co., Ltd.
10:00-10:30 / Keynote Speech: Asia's position and outlook in the life sciences industry Ms. Helen Chen, Partner and Head of China Life Sciences, L.E.K. Consulting
10:30-11:00 / Keynote Speech: Creating a Winning Life Sciences Innovation Strategy in an Era of Scarcity Mr. Steve Brown, Founder, Health Hero Network (acquired by Robert Bosch GmbH); Former EIR at Mohr Davidow Ventures; Chairman, Billionlights Foundation
11:00-12:00 / PANEL DISCUSSION-Challenges and Opportunities of Biotechnology Moderator: Helen Chen, Partner and Head of China Life Sciences, L.E.K. Consulting (Reserved) Panelists:
-1. Greg Scott,President, ChinaBio™ Accelerator, USA
-1. Alex Fowkes, Head of Strategic Alliances, Asia, Global Research & Development, Pfizer (China) Research and Development Co., Ltd.
-1. Steve Brown, Founder, Health Hero Network (acquired by Robert Bosch GmbH); Former EIR at Mohr Davidow Ventures; Chairman, Billionlights Foundation
-1. David A. Palella, President, BioScience Ventures, Inc., USA
12:00-13:00 / LUNCH BREAK
KEYNOTE SESSION I: CHINA BIOTECH – NEW VENTURE FRONTIER DAY 2: OCTOBER 12, 2008 (Sunday Morning)
Moderator: Mr. Alan S. Paau Vice Provost, Technology Transfer & Economic Development, Cornell University, USA; Executive Director, Cornell Center for Technology Enterprise & Commercialization (CCTEC), USA
09:00-09:25 / Keynote Title: Life Sciences Ventures in China: 15 years of Dramatic Change Mr. Charles Hsu, Partner, Bay City Capital, USA
09:25-09:50 / Keynote Title: Open Innovation as a Business Model - Roles of Academic Technology Transfer Mr. Alan S. Paau, Vice Provost, Technology Transfer & Economic Development, Cornell University; Executive Director, Cornell Center for Technology Enterprise & Commercialization (CCTEC), USA
09:50-10:15 / Keynote Speech: Merck’s Strategies of Pharma Innovations in China Ms. Jing-Shan (Jennifer) Hu, Director, Licensing & External Research (Mainland China, Hong Kong, & Taiwan), Worldwide Licensing & External Researcher, Merck & Co., USA
10:15-10:30 / COFFEE BREAK
Parallel Bio-VC Session Ⅱ: Opportunities & Challenges of Bio-Venture In China OCTOBER 12, 2008 (Sunday Morning)
Moderator: Mr. Tien-Lai Hwang Managing Director and General Manager, Acorn Campus Shanghai Management Co., Ltd
SPEECHES:
10:30-10:55 / Title: Innovation Sourcing in Asia – The Roche Pharma Partnering Approach Mr. Frank Grams, Business Development Director, Pharma Partnering Asia Shanghai Roche Pharmaceuticals Ltd, China
10:55-11:20 / Title: Bio-Venture in China Mr. Tien-Lai Hwang, Managing Director and General Manager, Acorn Campus Shanghai Management Co., Ltd
11:20-12:00 / PANEL DISCUSSION
Panelists:
-1. Mr. Frank Grams, Business Development Director, Pharma Partnering Asia, Shanghai Roche Pharmaceuticals Ltd
-1. Mr. Alan S. Paau, Vice Provost, Technology Transfer & Economic Development, Cornell University, USA; Executive Director, Cornell Center for Technology Enterprise & Commercialization (CCTEC), USA
-1. Mr. Roy Hua, Managing Partner, Columbus Growth, USA
-1. Ms. Jing-Shan (Jennifer) Hu, Director, Licensing & External Research (Mainland China, Hong Kong, & Taiwan), Worldwide Licensing & External Researcher, Merck & Co., USA
-1. Mr. Wai-Yan Sandy Chau, Managing Director, Acorn Campus Ventures, USA
-1. Mr. Charles Hsu, Partner, Bay City Capital, USA
12:00-13:00 / LUNCH BREAK
Parallel Bio-VC Session Ⅲ: New Bio or Pharma Business Models and Novel Fund-raising Vehicles in China OCTOBER 12, 2008 (Sunday Morning)
Moderator: Paul A. DeRidder Venture Partner, Crystal Cove Capital LLC, USA
SPEECHES:
10:30-10:55 / Title: China VC Market Landscape and Outlook Mr. York Chen, President, iD Tech Ventures
10:55-11:20 / Title: WI Harper Group Case Studies Mr. Wayne Shiong, Partner, WI Harper Group, China
11:20-12:00 / PANEL DISCUSSION
Panelists:
-1. Ian Goh, Partner, KPCB, China
-1. Xin Sylvia He, Director, Cofounder, Former CEO, RHEI Pharmaceuticals, China
-1. York Chen, Partner, iD TechVentures, China
-1. Hui Hsing Ma, Partner, TVM Capital
12:00-13:00 / LUNCH BREAK
Bio-VC SessionⅣ: How to Set up Good CMO, CRO of R & D Business DAY 3: OCTOBER 13, 2008 (Monday Morning)
Moderator: David A. Palella President, BioScience Ventures, Inc., USA
SPEECHES:
09:00-09:30 / Title: From Chemical to Clinical Trial William Hu (Hu XuBo), Partner, Qiming Venture Partners, China
09:30-10:00 / Title: Global Life Science Mind-to-Market Solution in China George Peng, Vice President, Venturepharm Group, China
10:00-11:00 / PANEL DISCUSSION:
Panelists:
-1. William Hu, (Hu XuBo), Partner, Qiming Venture Partners, China
-1. George Peng, Vice President, Venturepharm Group, China
-1. William Pay, Vice President, Strategic Development & Partner Engagement Global Clinical Services, Venturepharm Asia/ VPS CRO Group, USA
12:00-13:00 / LUNCH BREAK
Bio-VC Session Ⅴ:How to Obtain Seeding Money or Find Angel Investors OCTOBER 13, 2008 (Monday Morning)
Moderator: Greg Scott President, ChinaBio™ Accelerator, USA
SPEECHES:
09:00-09:30 / Title: VC and Angel Investment in China Biotech Greg Scott, President, ChinaBio™ Accelerator, USA
09:30-10:00 / Title: How to Invest Early Phase Biotech Companies GraceZhang, AtlasVenture,Beijing, China
10:00-11:00 / PANEL DISCUSSION
Panelists:
-1. Marc Schuele, Managing partner, DSM Venturing, The Netherlands
-1. Yi Shi, Ph.D., Managing Director, Lilly Asian Ventures, China
-1. Michael L. Huang, AVP, CX Venture Capital Group, Taiwan
12:00-13:00 / LUNCH BREAK